Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
4DMedical Ltd ( (AU:4DX) ) just unveiled an update.
4DMedical Ltd has applied for quotation on the ASX of 14,067,797 new ordinary fully paid shares, with an issue date of 2 April 2026. The additional securities, previously flagged in an Appendix 3B, will increase the company’s free float and capital base, potentially enhancing its funding capacity and liquidity in the market.
The move signals continued capital market activity by 4DMedical as it pursues its growth ambitions in respiratory imaging technology. For existing shareholders and prospective investors, the enlarged share pool may influence trading dynamics and valuation, depending on how effectively the new capital is deployed to advance the company’s commercial and operational objectives.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$6.00 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd is an Australian-listed medical technology company focused on diagnostic imaging. Trading under the ASX code 4DX, it develops and commercialises advanced respiratory imaging solutions, targeting clinicians and healthcare providers in pulmonary and respiratory care markets.
Average Trading Volume: 7,796,732
Technical Sentiment Signal: Buy
Current Market Cap: A$3.24B
For detailed information about 4DX stock, go to TipRanks’ Stock Analysis page.